Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells

Bladder cancer is the fourth most common type of cancer in men (ninth in women) in the United States. Cisplatin is an effective agent against the most common subtype, urothelial carcinoma. However, the development of chemotherapy resistance is a severe clinical problem for the successful treatment o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hour, Tzyh-Chyuan, Lai, Yan-Liang, Kuan, Ching-I, Chou, Chen-Kung, Wang, Ju-Ming, Tu, Huang-Yao, Hu, Huei-Ting, Lin, Chang-Shen, Wu, Wen-Jeng, Pu, Yeong-Shiau, Sterneck, Esta, Huang, A-Mei
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586239/
https://ncbi.nlm.nih.gov/pubmed/20385105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2010.04.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados